Direct and indirect effects of a PPARγ agonist and PPARα/γ dual agonist on the liver

被引：0
|
作者：
Wilbur, K
Hawkins, E
Dana, S
Brozinick, J
Rafaeloff-Phail, R
Reifel-Miller, A
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A578 / A578
页数：1
相关论文
共 50 条
  • [1] A PPARα agonist and a PPARα/γ dual agonist inhibit AMPK in livers of diabetic mice
    Rafaeloff-Phail, R
    Ding, LY
    Xiao, HL
    Wilbur, K
    Hawkins, E
    Dana, S
    Brozinick, J
    Baker, T
    Reifel-Miller, A
    DIABETES, 2004, 53 : A364 - A364
  • [2] Lipotoxic dilated cardiomyopathy in mice is exacerbated by a PPAR alpha agonist, but not by a dual agonist of PPAR alpha and PPAR gamma
    Vikramadithyan, RK
    Hirata, K
    Yagyu, H
    Hu, YY
    Homma, S
    Goldberg, IJ
    CIRCULATION, 2003, 108 (17) : 13 - 14
  • [3] Evaluation of Direct and Indirect Effects of the PPARγ Agonist Troglitazone on Mouse Endothelial Cell Proliferation
    Kakiuchi-Kiyota, Satoko
    Arnold, Lora L.
    Yokohira, Masanao
    Koza-Taylor, Petra
    Suzuki, Shugo
    Varney, Michelle
    Pennington, Karen L.
    Cohen, Samuel M.
    TOXICOLOGIC PATHOLOGY, 2011, 39 (07) : 1032 - 1045
  • [4] Antidiabetic effects of CKD-501, a PPARα/γ dual agonist
    Kwon, YM
    Ahn, JB
    Shin, JS
    Hwang, IC
    Moon, CK
    Lee, HW
    Kilahn, S
    Lee, SJ
    DIABETES, 2005, 54 : A124 - A124
  • [5] Netoglitazone -: Antidiabetic -: PPARα/PPARγ agonist
    Sorbera, LA
    Castañer, J
    del Fresno, M
    Silvestre, J
    DRUGS OF THE FUTURE, 2002, 27 (02) : 132 - 139
  • [6] Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification
    Zaware, Pandurang
    Shah, Shailesh R.
    Pingali, Harikishore
    Makadia, Pankaj
    Thube, Baban
    Pola, Suresh
    Patel, Darshit
    Priyadarshini, Priyanka
    Suthar, Dinesh
    Shah, Maanan
    Jamili, Jeevankumar
    Sairam, Kalapatapu V. V. M.
    Giri, Suresh
    Patel, Lala
    Patel, Harilal
    Sudani, Hareshkumar
    Patel, Hiren
    Jain, Mukul
    Patel, Pankaj
    Bahekar, Rajesh
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 628 - 632
  • [7] Discovery of FXR/PPAR? dual partial agonist
    Yamashita, Yukiko
    Gohda, Keigo
    Iguchi, Yusuke
    Fujimori, Ko
    Oda, Keisuke
    Masuda, Arisa
    Une, Mizuho
    Teno, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 85
  • [8] Antihypertensive potential of the dual PPAR α and γ agonist ragaglitazar
    Mamnoor, PK
    Datla, SR
    Damarla, RB
    Chakrabarti, R
    Kiran, K
    Rajagopalan, R
    DIABETES, 2002, 51 : A36 - A36
  • [9] PPARγ partial agonist activity and PPARα inverse agonist activity of capsaicin
    Yoshida, H
    Tamehiro, N
    Nishimaki-Mogami, T
    Inoue, K
    Ohno, Y
    Nagao, T
    Sato, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 236P - 236P
  • [10] Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
    Unni Syversen
    Astrid K Stunes
    Björn I Gustafsson
    Karl J Obrant
    Lars Nordsletten
    Rolf Berge
    Liv Thommesen
    Janne E Reseland
    BMC Endocrine Disorders, 9
12345